'Neil Woodford’s ‘error of judgement’ US investment now largely written off'
"We will always do everything that we can to ensure positive long-term outcomes for our investors, but this case study suggests that it is not always enough. The governance issues at Northwest Biotherapeutics have continued to conspire to shred investor confidence in the business.'" -Woodford